光生体刺激デバイスの市場：タイプ、用途、エンドユーザー、地域別、2024年～2031年

光生体刺激デバイスの市場評価、2024年～2031年

非侵襲的で薬物を使用しない治療技術への傾倒の高まりは、その有効性と安全性に対する認識の高まりが、光生体刺激デバイスの需要を煽っています。Verified Market Researchのアナリストによると、光生体刺激デバイス市場は、2023年の約1億9,582万米ドルを下回り、予測期間中に3億1,364万米ドルの評価に達すると推定されます。

市場は、ヘルスケア専門家や消費者が光生物刺激療法の利点を認識するにつれてペースを増しており、その結果、さまざまな医療現場でこれらのデバイスの使用が増加し、2024年から2031年にかけてCAGR 6.07%で市場が成長することを可能にしています。

光生体刺激デバイス市場定義/概要

低レベルレーザー治療（LLLT）またはコールドレーザーとしても知られる光生体刺激デバイスは、特定の波長の光を使用して体内の細胞プロセスを活性化します。これらの装置は非熱的な低強度の光を発生させ、それが細胞に吸収されることで、治癒や組織再生を促進するさまざまな生化学的反応が起こる。要するに、光バイオスティミュレーションは光の治療特性を利用して、身体に害を与えることなく自然治癒プロセスを促進させるのです。

さらに、これらの機器は医療や美容のさまざまな分野で活用されています。ヘルスケアでは、関節炎、腱炎、スポーツ外傷などの病気によって引き起こされる痛みを制御し、炎症を抑え、筋骨格系の痛みを和らげるために使用されます。光生体刺激デバイスはまた、糖尿病性潰瘍などの急性および慢性創傷の早期回復を促進する創傷治癒にも使用されています。

光生体刺激デバイスの成長を促進する要因は？

世界の人口は、神経障害性疼痛、筋骨格系障害、関節炎などの慢性疾患の影響を受けつつあります。その結果、光生体刺激デバイスは様々な状況において疼痛管理、炎症の軽減、組織治癒の促進に役立ち、このような治療オプションに対する需要が高まっています。

疼痛管理やリハビリテーションのための非侵襲的な方法は、ヘルスケア専門家や患者の間で大きな支持を得ています。この動向は、光バイオスティミュレーション療法の有効性と安全性を実証する臨床エビデンスの増加によって支えられており、その採用拡大に寄与しています。

さらに、レーザーとLED技術の継続的な進歩により、より効果的で携帯可能な使いやすい光生体刺激デバイスが開発されています。このような技術的進歩は、治療効果を向上させるだけでなく、家庭での使用をより身近なものにし、市場の成長をもたらしています。

光生体刺激デバイス市場の成長を抑制する限界は？

光生体刺激デバイスは潜在的な利点があるにもかかわらず、医療関係者からも消費者からも懐疑的な目で見られています。ヘルスケアプロバイダーや患者に新しい技術を使用するよう説得するのは大変なことであり、特にこれらの機器がどのように機能するかについての認識や理解が乏しい場合はなおさらです。その結果、市場にとって大きな障害となっています。

光生体刺激療法に対する保険償還の獲得も問題になる可能性があります。多くの保険会社は、費用対効果や長期的なベネフィットを示す強力なエビデンスがない限り、新規治療や開発中の治療を受け入れることに慎重です。このため、患者によっては自己負担が法外に高額な治療もあるため、こうした医薬品への患者アクセスが制限されます。

さらに、米国食品医薬品局（FDA）や欧州医薬品庁（EMA）などの規制機関からの承認も大きな障壁となっています。これらの機器は、高い安全性と有効性の要件を満たさなければならず、承認プロセスには時間と費用がかかります。

目次

第1章 光生体刺激デバイスの世界市場：イントロダクション

• 市場概要
• 調査範囲
• 前提条件

第2章 エグゼクティブサマリー

第3章 VERIFIED MARKET RESEARCHの調査手法

• データマイニング
• 検証
• プライマリーインタビュー
• データソース一覧

第4章 光生体刺激デバイスの世界市場展望

• 概要
• 市場力学
  • 促進要因
  • 抑制要因
  • 機会
• ポーターファイブフォースモデル
• バリューチェーン分析

第5章 光生体刺激デバイスの世界市場：タイプ別

• 概要
• 赤外線
• 赤色光
• その他

第6章 光生体刺激デバイスの世界市場：用途別

• 概要
• 疼痛管理
• 創傷治療
• 化粧品用途
• その他

第7章 光生体刺激デバイスの世界市場：エンドユーザー別

• 専門クリニック
• 研究機関
• 在宅医療
• その他

第8章 光生体刺激デバイスの世界市場：競合情勢

• 概要
• 各社の市場ランキング
• 主な開発戦略

第9章 企業プロファイル

• Lumenis
• BIOPTRON AG
• PhotoMedex Inc.
• Zimmer Biomet
• IRRAS
• LiteCure LLC
• Mettler Electronics Corp.
• TheraLight LLC
• Quantum Devices Inc.
• Diomed Medical Group

第10章 主な発展

• 製品上市／開発
• 合併と買収
• 事業拡大
• パートナーシップと提携

第11章 付録

• 関連調査

Photobiostimulation Devices Market Valuation - 2024-2031

The growing inclination toward non-invasive and drug-free therapeutic techniques is driven by increased awareness of their efficacy and safety, fueling demand for photobiostimulation devices. According to the analyst from Verified Market Research, the Photobiostimulation Devices Market is estimated to reach a valuation of USD 313.64 Million over the forecast subjugating aroundUSD 195.82 Million valued in 2023.

The market is gaining pace as healthcare professionals and consumers recognize the benefits of photobiostimulation therapy, resulting in increased usage of these devices in a variety of healthcare settings and enabling the market to grow at aCAGR of 6.07% from 2024 to 2031.

Photobiostimulation Devices Market: Definition/ Overview

Photobiostimulation devices, also known as low-level laser treatment (LLLT) or cold lasers, use certain wavelengths of light to activate cellular processes in the body. These devices produce non-thermal, low-intensity light that is absorbed by cells, resulting in a variety of biochemical responses that promote healing and tissue regeneration. In essence, photobiostimulation uses the therapeutic characteristics of light to accelerate the body's natural healing processes without causing harm.

Furthermore, these devices are utilized in a variety of medical and aesthetic disciplines. They are used in healthcare to control pain, reduce inflammation, and relieve musculoskeletal pain caused by illnesses such as arthritis, tendonitis, and sports injuries. Photobiostimulation devices are also used in wound healing to promote speedier recovery from both acute and chronic wounds, such as diabetic ulcers.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Which are the Drivers Fostering Growth of Photobiostimulation Devices?

The world's population is becoming more and more affected by chronic illnesses such as neuropathic pain, musculoskeletal disorders, and arthritis. As a result, photobiostimulation devices help manage pain, decrease inflammation, and encourage tissue healing in various situations, increasing the demand for such therapeutic options.

Non-invasive methods for pain management and rehabilitation have gained substantial traction among healthcare professionals and patients. This trend is supported by a rising amount of clinical evidence demonstrating the efficacy and safety of photobiostimulation therapy, contributing to its increasing adoption.

Furthermore, continuous advancements in laser and LED technology have resulted in the creation of more effective, portable, and user-friendly photobiostimulation devices. These technical advancements not only improve therapeutic efficacy but also make these devices more accessible for home use, hence growing the market.

Which are the Limitations Restraining Growth of Photobiostimulation Devices Market?

Despite their potential benefits, photobiostimulation devices are viewed skeptically by both the medical establishment and consumers. Convincing healthcare providers and patients to use new technology is tough, especially when there is little awareness or comprehension of how these devices work. As a result, it acts as a significant obstacle for the market.

Obtaining insurance reimbursement for photobiostimulation therapies is possible to be problematic. Many insurance companies are cautious to accept novel or developing treatments unless there is strong evidence of their cost-effectiveness and long-term benefits. This limits patient access to these medicines because some treatments may be prohibitively expensive for some patients to pay out of pocket.

Furthermore, approval from regulatory organizations such as the United States Food and Drug Administration (FDA) and the European Medicines Agency (EMA) is a substantial barrier. These devices have to satisfy high safety and efficacy requirements, and the approval process can be lengthy and expensive.

Category-Wise Acumens

How will Sales of Infrared Light Fare for The Market?

According to VMR analysis, the infrared light segment is estimated to hold the largest market share in the type segment during the forecast period. Infrared light treatment is used for a variety of purposes, including pain relief, inflammation reduction, muscle repair, and wound healing. Its versatility appeals to a wide range of users, including medical professionals, physical therapists, and patients seeking at-home therapy choices. This diverse range of applications helps to explain the reason infrared light devices are more widely used than other types of photobiostimulation devices.

Infrared light penetrates deeper into tissues than red light or other forms of light utilized in photobiostimulation. This deeper penetration is critical for treating problems that occur in deeper layers of tissue, making infrared devices particularly beneficial for a wide range of medical and therapeutic applications, including muscle discomfort, joint issues, and certain types of chronic pain. The capacity to penetrate deeper tissues increases the utility and effectiveness of infrared photobiostimulation devices, contributing to their dominant market position.

Furthermore, infrared light therapy's efficacy and safety have been validated by extensive clinical evidence, resulting in regulatory approval for a wide range of medical and therapeutic applications. This robust clinical backing reassures both healthcare providers and patients, encouraging the use of infrared light equipment. Regulatory approvals also assist the introduction of these technologies into mainstream healthcare settings, increasing their market penetration.

Which Drivers Boost Applications of Pain Management in the Market?

The pain management segment is estimated to grow at the highest CAGR in the Photobiostimulation Devices Market during the forecast period. The rising prevalence of chronic pain diseases such as arthritis, back pain, and neck pain, among others, adds significantly to the demand for pain management solutions. Photobiostimulation devices provide a non-invasive, drug-free pain relief option that appeals to a diverse variety of individuals seeking alternatives to pharmaceutical pain management.

Photobiostimulation devices are becoming increasingly popular among healthcare practitioners for pain management. This is due to a substantial body of clinical evidence demonstrating their usefulness in pain management and tissue healing. As these devices become more integrated into normal pain management protocols, their market share in this segment is increasing.

Furthermore, technological improvements have improved the effectiveness, affordability, and accessibility of photobiostimulation devices. Innovations in device design, such as portability and ease of use, have allowed patients to utilize these devices at home, increasing their popularity for pain management.

Country/Region-wise Acumens

Which Drivers Support North America's Dominant Position in the Market?

According to VMR analyst, North America is estimated to dominate the Photobiostimulation Devices Market during the forecast period. North America is demonstrating an increasing preference for non-invasive treatment choices. Photobiostimulation devices, which offer a non-invasive technique for controlling chronic pain, wound healing, and cosmetic applications, connect well with this trend and are becoming increasingly popular in the region.

North America is home to several competitors in the market, contributing to the region's dominant position in the photobiostimulation device market. The region's inclination towards adopting technologically advanced, minimally invasive therapies promoting the development and use of photobiostimulation devices. The region's strong healthcare infrastructure and high healthcare expenditure support market growth.

Furthermore, the regulatory framework in North America, particularly in the United States, promotes innovation and speedy clearance of medical devices, including photobiostimulation devices. This environment stimulates companies to create and commercialise innovative and effective therapies, boosting market growth.

What Variables Influence the Demand for these Devices in Asia Pacific Region?

Asia Pacific is estimated to grow at the highest CAGR within the market during the forecast period. Asia Pacific has a large and expanding elderly population, making it more vulnerable to chronic illnesses that can be addressed using photobiostimulation devices, such as pain relief, wound treatment, and cosmetic applications. As these illnesses become more common, there is a greater need for photobiostimulation therapy.

Countries in Asia Pacific, particularly China and India, are experiencing significant economic expansion, resulting in higher healthcare spending. Such economic growth has increased access to healthcare services and modern medical technologies, such as photobiostimulation devices.

Furthermore, this region is experiencing an increase in the use of non-invasive treatments. Photobiostimulation devices are a non-invasive alternative to standard medical treatments for a range of illnesses, matching patient preferences and driving market expansion in the region.

Competitive Landscape

The Photobiostimulation Devices Market is characterized by dynamic interactions between numerous companies competing for market share. Market companies are constantly striving to differentiate themselves by developing innovative photobiostimulation devices with improved efficacy, safety features, and usability.

Some of the prominent players operating in the Photobiostimulation Devices Market include:

Lumenis, BIOPTRON AG, PhotoMedex Inc., Zimmer Biomet, IRRAS, LiteCure LLC, Mettler Electronics Corp., TheraLight LLC, Quantum Devices Inc., Diomed Medical Group, Aktiia, BIOLUX, INTERNATIONAL CORP., CellGen Therapeutics, Cytalux Corporation, LED Medical Diagnostics Inc., LG Innotek, Koninklijke Philips N.V., MOSER BAER AG, PhotoSonix Medical Inc., and Verilux Inc.

Latest Developments

In February 2024, BIOPTRON AG presented positive clinical data on the use of photobiostimulation treatment devices for wound healing at the Dubai World Dermatology Congress. The study discovered that the therapy dramatically decreased healing time while improving patient outcomes.

In February 2024, MOSER BAER announced an increase in its LED manufacturing capacity to accommodate the growing demand for photobiostimulation devices. This investment will allow the company to help its customers grow in this area.

In January 2024, PhotoMedex established a strategic agreement with Zimmer Biomet to develop and commercialise photobiostimulation devices for orthopaedic purposes. This alliance aims to harness both organisations' expertise to bring innovative ideas to market.

In October 2023, Philips announced a collaboration with the University of Amsterdam to investigate the use of photobiostimulation to treat brain problems. This collaboration seeks to investigate the potential of this technology for neurological applications.

In October 2023, Lumenis announced the Aculight(TM) Cynosure Laser System, a photobiostimulation therapy device to treat chronic pain and inflammation. The company says that the system has deeper tissue penetration and faster treatment times than previous models.

TABLE OF CONTENTS

1 INTRODUCTION OF THE GLOBAL PHOTOBIOSTIMULATION DEVICES MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL PHOTOBIOSTIMULATION DEVICES MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porter Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL PHOTOBIOSTIMULATION DEVICES MARKET, BY TYPE

• 5.1 Overview
• 5.2 Infrared Light
• 5.3 Red Light
• 5.4 Others

6 GLOBAL PHOTOBIOSTIMULATION DEVICES MARKET, BY APPLICATION

• 6.1 Overview
• 6.2 Pain Management
• 6.3 Wound Care
• 6.4 Cosmetic Applications
• 6.5 Others

7 GLOBAL PHOTOBIOSTIMULATION DEVICES MARKET, BY END USER

• 7.1 Specialty Clinics
• 7.2 Research Institutes
• 7.3 Home Care
• 7.4 Others

8 GLOBAL PHOTOBIOSTIMULATION DEVICES MARKET COMPETITIVE LANDSCAPE

• 8.1 Overview
• 8.2 Company Market Ranking
• 8.3 Key Development Strategies

9 COMPANY PROFILES

• 9.1 Lumenis
  • 9.1.1 Overview
  • 9.1.2 Financial Performance
  • 9.1.3 Product Outlook
  • 9.1.4 Key Developments
• 9.2 BIOPTRON AG
  • 9.2.1 Overview
  • 9.2.2 Financial Performance
  • 9.2.3 Product Outlook
  • 9.2.4 Key Developments
• 9.3 PhotoMedex Inc.
  • 9.3.1 Overview
  • 9.3.2 Financial Performance
  • 9.3.3 Product Outlook
  • 9.3.4 Key Developments
• 9.4 Zimmer Biomet
  • 9.4.1 Overview
  • 9.4.2 Financial Performance
  • 9.4.3 Product Outlook
  • 9.4.4 Key Developments
• 9.5 IRRAS
  • 9.5.1 Overview
  • 9.5.2 Financial Performance
  • 9.5.3 Product Outlook
  • 9.5.4 Key Developments
• 9.6 LiteCure LLC
  • 9.6.1 Overview
  • 9.6.2 Financial Performance
  • 9.6.3 Product Outlook
  • 9.6.4 Key DevelopmentS
• 9.7 Mettler Electronics Corp.
  • 9.7.1 Overview
  • 9.7.2 Financial Performance
  • 9.7.3 Product Outlook
  • 9.7.4 Key Developments
• 9.8 TheraLight LLC
  • 9.8.1 Overview
  • 9.8.2 Financial Performance
  • 9.8.3 Product Outlook
  • 9.8.4 Key Developments
• 9.9 Quantum Devices Inc.
  • 9.9.1 Overview
  • 9.9.2 Financial Performance
  • 9.9.3 Product Outlook
  • 9.9.4 Key Developments
• 9.10 Diomed Medical Group
  • 9.10.1 Overview
  • 9.10.2 Financial Performance
  • 9.10.3 Product Outlook
  • 9.10.4 Key Developments

10 KEY DEVELOPMENTS

• 10.1 Product Launches/Developments
• 10.2 Mergers and Acquisitions
• 10.3 Business Expansions
• 10.4 Partnerships and Collaborations

11 Appendix

• 11.1 Related Research